Extracardiac medical and neuromuscular implications in restrictive cardiomyopathy.
Restrictive cardiomyopathy (RCMP) is characterized by restrictive filling and reduced diastolic volume of either or both ventricles with normal or near-normal systolic function and wall thickness. It may occur idiopathically or as a cardiac manifestation of systemic diseases such as scleroderma, amyloidosis, Churg-Strauss syndrome, cystinosis, sarcoidosis, lymphoma, Gaucher's disease, hemochromatosis, Fabry's disease, pseudoxanthoma elasticum, hypereosinophilic syndrome, carcinoid, Noonan's syndrome, reactive arthritis, or Werner's syndrome and various neuromuscular disorders. Whereas in idiopathic RCMP the therapeutic options are only treatment of cardiac congestion, in cases with an underlying disorder, a causal therapy may be available. Patients with RCMP should be investigated as soon as the cardiac diagnosis is established for extracardiac diseases to detect a possibly treatable cause of RCMP before the disease becomes intractable. These investigations include a diligent clinical history and examination, blood tests, and ophthalmologic, otologic, dermatologic, gastroenterologic, nephrologic, hematologic, and neurologic examinations. If extracardiac examinations do not reveal a plausible cause for RCMP, endomyocardial biopsy is indicated.
Medizinische Abteilung, Krankenanstalt Rudolfstiftung, Vienna, Austria. claudia.stoellberger@chello.at
Claudia
C
Stöllberger
Josef
J
Finsterer
D015415:Biomarkers / Q000097:blood; D001706:Biopsy; D006328:Cardiac Catheterization; D002313:Cardiomyopathy, Restrictive / Q000150:complications* / Q000175:diagnosis / Q000235:genetics / Q000503:physiopathology* / Q000628:therapy; D004452:Echocardiography; D004562:Electrocardiography; D004699:Endocardium / Q000473:pathology; D020022:Genetic Predisposition to Disease; D006801:Humans; D009206:Myocardium / Q000473:pathology; D009468:Neuromuscular Diseases / Q000209:etiology*; D013318:Stroke Volume; D017725:Ventricular Pressure
D015415:Biomarkers